Delivery Order SPE2DB22D2007-SPE2DB25FJ0LU

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,328.78, is for the delivery of COPAXONE 40 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of June 17, 2024 and is a Firm Fixed Price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $2,925.40, is a delivery order for the supply of COPAXONE 20 MG/ML SYRINGE/ML. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Copaxone 20 mg/mL syringes to support the Defense Logistics Agency (DLA) Troop Support Medical. The $1,083.79 firm fixed-price delivery order has a completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,583.28, is for the delivery of COPAXONE 40 MG/ML syringes and is a Firm Fixed Price Delivery Order. The award does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these medical supplies to support the healthcare needs of the U.S. military and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, with a ceiling value of $1,092.00 and a period of performance through May 14, 2025. This delivery order is not set aside and is priced on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. The $2,232.72 Firm Fixed Price Delivery Order is for the supply of Copaxone 40 mg/ml syringes, a prescription medication. The contract has an ultimate completion date of July 10, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a much larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 fixed-price delivery order is for the supply of COPAXONE 40 MG/ML, a specialty pharmaceutical product. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Copaxone 40 mg/ml syringes, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,638.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) to provide COPAXONE 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The $24,288.34 firm-fixed-price delivery order has a completion date of December 21, 2021 and was awarded on December 20, 2021. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0LU
    Delivery Order

This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is a Firm Fixed Price Delivery Order for the supply of COPAXONE 40 MG/ML syringes. The contract has an ultimate completion date of April 8, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 7/7/25, 1:13 PM